65 related articles for article (PubMed ID: 20970865)
1. (18)F-FDG PET bio-metabolic monitoring of neoadjuvant therapy effects in rectal cancer: focus on nodal disease characteristics.
Calvo FA; Cabezón L; González C; Soria A; de la Mata D; Gómez-Espí M; García-Alfonso P; Alvarez E; Carreras JL
Radiother Oncol; 2010 Nov; 97(2):212-6. PubMed ID: 20970865
[TBL] [Abstract][Full Text] [Related]
2. The use of PET in assessing tumor response after neoadjuvant chemoradiation for rectal cancer.
Mak D; Joon DL; Chao M; Wada M; Joon ML; See A; Feigen M; Jenkins P; Mercuri A; McNamara J; Poon A; Khoo V
Radiother Oncol; 2010 Nov; 97(2):205-11. PubMed ID: 20598390
[TBL] [Abstract][Full Text] [Related]
3. FDG-PET imaging for lymph node staging and pathologic tumor response after neoadjuvant treatment of non-small cell lung cancer.
Ohtsuka T; Nomori H; Ebihara A; Watanabe K; Kaji M; Naruke T; Suemasu K; Uno K
Ann Thorac Cardiovasc Surg; 2006 Apr; 12(2):89-94. PubMed ID: 16702929
[TBL] [Abstract][Full Text] [Related]
4. A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer.
Kauhanen SP; Komar G; Seppänen MP; Dean KI; Minn HR; Kajander SA; Rinta-Kiikka I; Alanen K; Borra RJ; Puolakkainen PA; Nuutila P; Ovaska JT
Ann Surg; 2009 Dec; 250(6):957-63. PubMed ID: 19687736
[TBL] [Abstract][Full Text] [Related]
5. The accuracy of endoscopic ultrasonography with fine-needle aspiration, integrated positron emission tomography with computed tomography, and computed tomography in restaging patients with esophageal cancer after neoadjuvant chemoradiotherapy.
Cerfolio RJ; Bryant AS; Ohja B; Bartolucci AA; Eloubeidi MA
J Thorac Cardiovasc Surg; 2005 Jun; 129(6):1232-41. PubMed ID: 15942562
[TBL] [Abstract][Full Text] [Related]
6. Whole-body positron emission tomography using 18F-fluorodeoxyglucose compared to standard procedures for staging patients with Hodgkin's disease.
Jerusalem G; Beguin Y; Fassotte MF; Najjar F; Paulus P; Rigo P; Fillet G
Haematologica; 2001 Mar; 86(3):266-73. PubMed ID: 11255273
[TBL] [Abstract][Full Text] [Related]
7. Response to preoperative short-course radiotherapy in locally advanced rectal cancer: value of f-fluorodeoxyglucose positron emission tomography.
Siegel R; Dresel S; Koswig S; Gebauer B; Hunerbein M; Schneider W; Schlag PM
Onkologie; 2008 Apr; 31(4):166-72. PubMed ID: 18418017
[TBL] [Abstract][Full Text] [Related]
8. High-grade endometrial cancer: value of [(18)F]FDG PET/CT in preoperative staging.
Picchio M; Mangili G; Samanes Gajate AM; De Marzi P; Spinapolice EG; Mapelli P; Giovacchini G; Sigismondi C; Viganò R; Sironi S; Messa C
Nucl Med Commun; 2010 Jun; 31(6):506-12. PubMed ID: 20168262
[TBL] [Abstract][Full Text] [Related]
9. Comparison of magnetic resonance imaging-fluorodeoxy- glucose positron emission tomography fusion with pathological staging in rectal cancer.
Kam MH; Wong DC; Siu S; Stevenson AR; Lai J; Phillips GE
Br J Surg; 2010 Feb; 97(2):266-8. PubMed ID: 20035542
[TBL] [Abstract][Full Text] [Related]
10. Preoperative intrathoracic lymph node staging in patients with non-small-cell lung cancer: accuracy of integrated positron emission tomography and computed tomography.
Billé A; Pelosi E; Skanjeti A; Arena V; Errico L; Borasio P; Mancini M; Ardissone F
Eur J Cardiothorac Surg; 2009 Sep; 36(3):440-5. PubMed ID: 19464906
[TBL] [Abstract][Full Text] [Related]
11. Circulating tumor cells and [18F]fluorodeoxyglucose positron emission tomography/computed tomography for outcome prediction in metastatic breast cancer.
De Giorgi U; Valero V; Rohren E; Dawood S; Ueno NT; Miller MC; Doyle GV; Jackson S; Andreopoulou E; Handy BC; Reuben JM; Fritsche HA; Macapinlac HA; Hortobagyi GN; Cristofanilli M
J Clin Oncol; 2009 Jul; 27(20):3303-11. PubMed ID: 19451443
[TBL] [Abstract][Full Text] [Related]
12. Integrated fluorine-18 fluorodeoxyglucose (18F-FDG) PET/CT compared to standard contrast-enhanced CT for characterization and staging of pulmonary tumors eligible for surgical resection.
Quaia E; Tona G; Gelain F; Lubin E; Pizzolato R; Boscolo E; Bussoli L
Acta Radiol; 2008 Nov; 49(9):995-1004. PubMed ID: 18651256
[TBL] [Abstract][Full Text] [Related]
13. 18F-FDG PET/CT for staging of penile cancer.
Scher B; Seitz M; Reiser M; Hungerhuber E; Hahn K; Tiling R; Herzog P; Reiser M; Schneede P; Dresel S
J Nucl Med; 2005 Sep; 46(9):1460-5. PubMed ID: 16157528
[TBL] [Abstract][Full Text] [Related]
14. Feasibility of [18F]FDG-PET and coregistered CT on clinical target volume definition of advanced non-small cell lung cancer.
Messa C; Ceresoli GL; Rizzo G; Artioli D; Cattaneo M; Castellone P; Gregorc V; Picchio M; Landoni C; Fazio F
Q J Nucl Med Mol Imaging; 2005 Sep; 49(3):259-66. PubMed ID: 16172572
[TBL] [Abstract][Full Text] [Related]
15. Is local excision after complete pathological response to neoadjuvant chemoradiation for rectal cancer an acceptable treatment option?
Kundel Y; Brenner R; Purim O; Peled N; Idelevich E; Fenig E; Sulkes A; Brenner B
Dis Colon Rectum; 2010 Dec; 53(12):1624-31. PubMed ID: 21178856
[TBL] [Abstract][Full Text] [Related]
16. Prevention of brown adipose tissue activation in 18F-FDG PET/CT of breast cancer patients receiving neoadjuvant systemic therapy.
Aukema TS; Vogel WV; Hoefnagel CA; Valdés Olmos RA
J Nucl Med Technol; 2010 Mar; 38(1):24-7. PubMed ID: 20159933
[TBL] [Abstract][Full Text] [Related]
17. The role of 18F-FDG PET in assessing therapy response in cancer of the cervix and ovaries.
Schwarz JK; Grigsby PW; Dehdashti F; Delbeke D
J Nucl Med; 2009 May; 50 Suppl 1():64S-73S. PubMed ID: 19380409
[TBL] [Abstract][Full Text] [Related]
18. The use of FDG-PET/CT and diffusion-weighted magnetic resonance imaging for response prediction before, during and after preoperative chemoradiotherapy for rectal cancer.
Lambrecht M; Deroose C; Roels S; Vandecaveye V; Penninckx F; Sagaert X; van Cutsem E; de Keyzer F; Haustermans K
Acta Oncol; 2010 Oct; 49(7):956-63. PubMed ID: 20586658
[TBL] [Abstract][Full Text] [Related]
19. Liver metabolic activity changes over time with neoadjuvant therapy in locally advanced rectal cancer.
Demir Y; Sürücü E; Şengöz T; Koç M; Kaya GÇ
Nucl Med Commun; 2016 Feb; 37(2):116-21. PubMed ID: 26440564
[TBL] [Abstract][Full Text] [Related]
20. Functional response imaging following neoadjuvant therapy for rectal cancer.
Smeets P; Ceelen W
Surg Technol Int; 2009 Apr; 18():93-7. PubMed ID: 19579194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]